AnalystsAndres Maldonado
Andres Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4558 out of 4986 analysts
Average Return
-2.97%
Win Rate
30%29 out of 96
Risk vs Reward
Poor
Good

Andres Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Scholar Rock Holding CorpSRRK
+314.00%$8.07$33.41
2024-06-25 -
2025-06-24
Buy
Scholar Rock Holding CorpSRRK
+228.91%$8.06$26.51
2023-10-12 -
2024-10-11
Buy
Scholar Rock Holding CorpSRRK
+215.71%$9.80$30.94
2024-06-04 -
2025-06-03
Buy
Scholar Rock Holding CorpSRRK
+182.30%$10.79$30.46
2024-05-23 -
2025-05-22
Buy
Werewolf Therapeutics IncHOWL
+180.18%$2.17$6.08
2023-03-23 -
2024-03-22
Buy

Andres Maldonado Analyst Color

Get additional color on Andres Maldonado's coverage of popular stocks

Andres Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
I MabIMAB
1Buy$7.00+66.27%Reiterates
a month ago
Immunitybio IncIBRX
4Buy$8.00+250.88%Reiterates
3 months ago
Aura Biosciences IncAURA
1Buy$22.00+243.75%Assumes
3 months ago
Zentalis Pharmaceuticals IncZNTL
1Buy$10.00+528.93%Reiterates
3 months ago
Corbus Pharmaceuticals Holdings IncCRBP
2Buy$40.00+338.12%Maintains
3 months ago
Tscan Therapeutics IncTCRX
1Buy$10.00+495.24%Maintains
3 months ago
Erasca IncERAS
10Buy$6.00+294.74%Reiterates
4 months ago
Foghorn Therapeutics IncFHTX
1Buy$13.00+169.15%Reiterates
4 months ago
Sutro Biopharma IncSTRO
1Hold$2.00+132.02%Reiterates
4 months ago
Protara Therapeutics IncTARA
1Buy$23.00+654.10%Reiterates
4 months ago
Cg Oncology IncCGON
13Buy$75.00+193.43%Reiterates
4 months ago
Day One Biopharmaceuticals IncDAWN
14Buy$36.00+427.86%Reiterates
5 months ago
Mural Oncology PLCMURA
5Buy$6.00+233.33%Maintains
5 months ago
Werewolf Therapeutics IncHOWL
16Buy$15.00+1,081.10%Reiterates
5 months ago
Engene Holdings IncENGN
2Buy$25.00+557.89%Reiterates
5 months ago
Scholar Rock Holding CorpSRRK
13Buy$50.00+66.00%Maintains
9 months ago
Imagenebio IncIMA
11Buy$48.00+241.88%Reiterates
9 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.